EDGAR Filing Documents for 0001193125-13-367478

Form 8-K - Current report:

SEC Accession No. 0001193125-13-367478

Filing Date

2013-09-16

Accepted

2013-09-16 11:26:36

Documents

Period of Report

2013-09-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d596819d8k.htm	8-K	25188
2	EX-1.1	d596819dex11.htm	EX-1.1	283191
3	EX-5.1	d596819dex51.htm	EX-5.1	11738
4	EX-99.1	d596819dex991.htm	EX-99.1	6586
5	EX-99.2	d596819dex992.htm	EX-99.2	5309
6	GRAPHIC	g596819g42g81.jpg	GRAPHIC	4675
7	GRAPHIC	g596819g79w70.jpg	GRAPHIC	3224
	Complete submission text file	0001193125-13-367478.txt		344516

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604

Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 131097992
SIC: 2834 Pharmaceutical Preparations